Fluocinolone Acetonide in Diabetic Macular Edema

Trial Profile

Fluocinolone Acetonide in Diabetic Macular Edema

Completed
Phase of Trial: Phase III

Latest Information Update: 03 Oct 2017

At a glance

  • Drugs Fluocinolone acetonide (Primary)
  • Indications Diabetic macular oedema
  • Focus Registrational; Therapeutic Use
  • Acronyms FAME
  • Sponsors Alimera Sciences
  • Most Recent Events

    • 03 Oct 2017 According to an Alimera Sciences media release, data from FAME Study will be presented during the 2017 Annual Meeting of the Retina Society 2017.
    • 09 Aug 2017 According to an Alimera Sciences media release, data will be presented at the 2017 American Society of Retinal Specialists (ASRS) Annual Meeting.
    • 16 Nov 2015 According to an Alimera Sciences media release, results of this study will be presented at the American Academy of Ophthalmology Annual Meeting 2015.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top